Modern role for clopidogrel in management of atrial fibrillation and stroke reduction

References

• GoASHylekEMPhillipsKAPrevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) StudyJAMA20012852370237511343485
   PubMed Web of Science ®Google Scholar
• SchnabelRBSullivanLMLevyDDevelopment of a risk score for atrial fibrillation (Framingham Heart Study): A community-based cohort studyLancet200937373974519249635
   PubMed Web of Science ®Google Scholar
• HartRGPearceLAAguilarMIMeta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillationAnn Intern Med200714685786717577005
   PubMed Web of Science ®Google Scholar
• LipGNieuwlaatRPistersRLaneDCrijnsHRefining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor based approach: The Euro Heart Survey on Atrial FibrillationChest201013726327219762550
   PubMed Web of Science ®Google Scholar
• NieuwlaatROlssonSBLipGYEuro Heart Survey InvestigatorsGuideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial FibrillationAm Heart J20071531006101217540203
   PubMed Web of Science ®Google Scholar
• HirshJDalenJAndersonDROral anticoagulants: Mechanism of action, clinical effectiveness, and optimal therapeutic rangeChest2001119SupplS8S21
   Google Scholar
• HaasSNew oral Xa and IIa inhibitors: Updates on clinical trial resultsJ Thromb Thrombolysis200825526017965837
   PubMed Web of Science ®Google Scholar
• BatesSMGinsbergJSClinical practice. Treatment of deep vein thrombosisN Engl J Med200435126827715254285
   PubMed Web of Science ®Google Scholar
• MackmanNTriggers, targets and treatments for thrombosisNature200845191491818288180
   PubMed Web of Science ®Google Scholar
• ConnollySJEzekowitzMDYusufSRE-LY Steering Committee and InvestigatorsDabigatran versus warfarin in patients with atrial fibrillationN Engl J Med20093611139115119717844
   PubMed Web of Science ®Google Scholar
• PatronoCBaigentCHirshJRothGAmerican College of Chest PhysiciansAntiplatelet drugs: American College of Chest Physicians evidence-based clinical practice guidelines8th ed.Chest2008133Suppl199233
   Google Scholar
• WallentinLP2Y(12) inhibitors: Differences in properties and mechanisms of action and potential consequences for clinical useEur Heart J2009301964197719633016
   PubMed Web of Science ®Google Scholar
• PortoIGiubilatoSDe MariaGLBiasucciLMCreaFPlatelet P2Y12 receptor inhibition by thienopyridines: Status and futureExpert Opin Investig Drugs20091813171332
   PubMed Web of Science ®Google Scholar
• HashemzadehMGoldsberrySFurukawaMKhoynezhadAMovahedMRADP receptor-blocker thienopyridines: Chemical structures, mode of action and clinical use. A reviewJ Invasive Cardiol20092140641219652255
   PubMed Web of Science ®Google Scholar
• MotovskaZWidimskyPClopidogrel before elective percutaneous coronary interventionJ Clin Pharmacol2009929 [Epub ahead of print].
   Google Scholar
• SingerDEAlbersGWDalenJEAmerican College of Chest PhysiciansAntithrombotic therapy in atrial fibrillation: American College of Chest Physicians evidence-based clinical practice guidelines8th ed.Chest2008133Suppl54659218252921
   PubMedGoogle Scholar
• LeviMHobbsFDJacobsonAKImproving antithrombotic management in patients with atrial fibrillation: Current status and perspectivesSemin Thromb Hemost20093552754219787556
   PubMed Web of Science ®Google Scholar
• LeysDBalucaniCCordonnierCAntiplatelet drugs for ischemic stroke preventionCerebrovasc Dis200927112012519342841
   PubMedGoogle Scholar
• VaneJRMeadeTWSecond European Stroke Prevention Study (ESPS 2): Clinical and pharmacological implicationsJ Neurol Sci19971451231259094039
   PubMedGoogle Scholar
• TijssenJGLow-dose and high-dose acetylsalicylic acid, with and without dipyridamole: A review of clinical trial resultsNeurology199851S15S169744825
   PubMedGoogle Scholar
• DienerHCSaccoRLYusufSPrevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) study group. Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: A double-blind, active and placebo-controlled studyLancet Neurol2008787588418757238
   PubMed Web of Science ®Google Scholar
• FergusonJJ3rdGonzalezERKannelWBOlinJWRapsECClinical safety and efficacy of clopidogrel – implications of the Clopidogrel versus Aspirin in Patients at Risk of Ischemic Events (CAPRIE) study for future management of atherosclerotic diseaseClin Ther1998204253
   Google Scholar
• LaiKCChuKMHuiWMEsomeprazole with aspirin versus clopidogrel for prevention of recurrent gastrointestinal ulcer complicationsClin Gastroenterol Hepatol2006486086516797240
   PubMed Web of Science ®Google Scholar
• HoPMMaddoxTMWangLRisk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndromeJAMA200930193794419258584
   PubMed Web of Science ®Google Scholar
• DienerHCBogousslavskyJBrassLMMATCH investigatorsAspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): Randomised, double-blind, placebo-controlled trialLancet200436433133715276392
   PubMed Web of Science ®Google Scholar
• BhattDLFoxKAHackeWCHARISMA InvestigatorsClopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic eventsN Engl J Med20063541706171716531616
   PubMed Web of Science ®Google Scholar
• BhattDLFlatherMDHackeWCHARISMA InvestigatorsPatients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trialJ Am Coll Cardiol2007491982198817498584
   PubMed Web of Science ®Google Scholar
• ConnollySYusufSBudajARationale and design of ACTIVE: The atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular eventsAm Heart J20061511187119316781218
   PubMed Web of Science ®Google Scholar
• ConnollySPogueJHartRClopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): A randomised controlled trialLancet20063671903191216765759
   PubMed Web of Science ®Google Scholar
• BennettCLConnorsJMCarwileJMThrombotic thrombocytopenic purpura associated with clopidogrelN Engl J Med20003421773177710852999
   PubMed Web of Science ®Google Scholar
• ZakarijaAKwaanHCMoakeJLTiclopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): Review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989–2008)Kidney Int Suppl2009112S20S2419180126
   PubMedGoogle Scholar
• BennettCLKimBZakarijaASERF-TTP Research GroupTwo mechanistic pathways for thienopyridine-associated thrombotic thrombocytopenic purpura: A report from the SERF-TTP Research Group and the RADAR ProjectJ Am Coll Cardiol2007501138114317868804
   PubMed Web of Science ®Google Scholar
• CarrelTEnglbergerLCoronary bypass surgery in patients treated with clopidogrel. Is it safe?Curr Opin Cardiol2009813
   Google Scholar
• AndersonJLAdamsCDAntmanEMAmerican College of Cardiology; American Heart Association Task Force on Practice GuidelinesACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice GuidelinesJ Am Coll Cardiol200750115717601538
   PubMed Web of Science ®Google Scholar
• JuurlinkDNGomesTKoDTA population-based study of the drug interaction between proton pump inhibitors and clopidogrelCMAJ200918071371819176635
   PubMed Web of Science ®Google Scholar
• RubboliAHalperinJLAiraksinenJAntithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillationAnnals of Medicine20084042843618608125
   PubMed Web of Science ®Google Scholar
• MaegdefesselLSchlittAFaerberJAnticoagulant and/or antiplatelet treatment in patients with atrial fibrillation after percutaneous coronary intervention. A single-center experienceMed Klin2008103628632
   Google Scholar
• KarjalainenPPPorelaPYlitaloAVikmanSNymanKVaittinenMASafety and efficacy of combined antiplatelet-warfarin therapy after coronary stentingEur Heart J20072872673217267456
   PubMed Web of Science ®Google Scholar
• PalaretiGManottiCDAngeloAThrombotic events during oral anticoagulant treatment: Results of the inception-cohort, prospective, collaborative ISCOAT study. ISCOAT study group (Italian Study on Complications of Oral Anticoagulant Therapy)Thromb Haemost199778143814439423791
   PubMed Web of Science ®Google Scholar
• GoASHylekEMBorowskyLHPhillipsKASelbyJVSingerDEWarfarin use among ambulatory patients with nonvalvular atrial fibrillation: The anticoagulation and risk factors in atrial fibrillation (ATRIA) studyAnn Intern Med199913192793410610643
   PubMed Web of Science ®Google Scholar
• GageBFWatermanADShannonWBoechlerMRichMWRadfordMJValidation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial FibrillationJAMA20012852864287011401607
   PubMed Web of Science ®Google Scholar
• GageBFvan WalravenCPearceLSelecting patients with atrial fibrillation for anticoagulation: Stroke risk stratification in patients taking aspirinCirculation20041102287229215477396
   PubMed Web of Science ®Google Scholar
• PistersRde VosCBNieuwlaatRCrijnsHJUse and underuse of oral anticoagulation for stroke prevention in atrial fibrillation: Old and new paradigmsSemin Thromb Hemost20093555455919787559
   PubMed Web of Science ®Google Scholar
• LeviMde PeuterORKamphuisenPWManagement strategies for optimal control of anticoagulation in patients with atrial fibrillationSemin Thromb Hemost20093556056719787560
   PubMed Web of Science ®Google Scholar
• HylekEMAntithrombotic prophylaxis in elderly patients with atrial fibrillationSemin Thromb Hemost20093554855319787558
   PubMed Web of Science ®Google Scholar
• MacDougallNJAmarasingheSMuirKWSecondary prevention of strokeExpert Rev Cardiovasc Ther200971103111519764863
   PubMedGoogle Scholar
• BousserMGAntithrombotic agents in the prevention of ischemic strokeCerebrovasc Dis200927121919439936
   PubMedGoogle Scholar
• EikelboomJEWeitzJIDabigatran etexilate for prevention of venous thromboembolismThromb Haemost20091012419132179
   PubMedGoogle Scholar
• HaasSNew anticoagulants – towards the development of an “ideal” anticoagulantVasa200938132919229800
   PubMed Web of Science ®Google Scholar